Vaccines
-
Hospital patients often pick up dangerous, hard to treat infections. An experimental vaccine given on arrival to hospital could protect against a range of drug-resistant bacteria and fungi, by activating a different arm of the immune system.
-
Sure, parts of the world are understandably feeling a bit of vaccine fatigue. But we're not too far off the first combination mRNA jab, which aims to offer seasonal protection against COVID-19 and influenza. Moderna hopes to be first out of the blocks.
-
The 2023 Nobel Prize in Physiology or Medicine has been awarded to biochemist Katalin Karikó and immunologist Drew Weissman for discoveries that enabled the development of mRNA vaccines against COVID-19.
-
An ‘inverse vaccine’ has been developed that reverses the damage caused when the immune system mistakenly attacks the body’s healthy organs and tissues. It could pave the way to a treatment for autoimmune diseases like MS, type 1 diabetes and arthritis.
-
Researchers are close to human clinical trials to test the safety and efficacy of vaccines to prevent heroin and fentanyl overdoses. If approved, they could revolutionize the treatment of opioid addiction and reduce deaths from overdose.
-
A study last year found that the influenza vaccine reduced the risk of Alzheimer's disease. Now, the same research team has found that people aged 65 and over who’ve received routine vaccinations are significantly less likely to develop the condition.
-
Researchers have developed a groundbreaking vaccine that generates immunity against the Epstein-Barr virus, a virus that almost all of us carry and which has been found to be a primary cause of diseases like multiple sclerosis and some cancers.
-
Caltech scientists have developed a new hybrid vaccine that combines mRNA and protein nanoparticles. In mouse tests, the prototype produced five times more antibodies than existing COVID-19 vaccines, and could be used against a range of diseases.
-
Researchers have designed a new nanoparticle that was shown to more effectively deliver a cancer-fighting mRNA vaccine to mice. The study’s results may lead to the development of better vaccines to treat cancer and infectious diseases like COVID-19.
-
Biotech giant Vaxxas has cut the ribbon on a warehouse manufacturing plant for its needle-free patches. After successful trials, the first needle-free, easy to store and easy to administer vaccines are set to be rolled out in as little as three years.
-
It may seem like snail's pace compared to our COVID-19 vaccines, but the wheels are certainly turning in the development of a universal mRNA influenza vaccine. The latest has just entered trial, with many others at the same stage or even further along.
-
Three times more men than women develop mouth and throat cancers, most likely caused by HPV, the world's most common STI. There's a vaccine that can prevent 90% of these HPV-related cancers, however it's mainly women getting the shots.
Load More